MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
EVX — VanEck Environmental Services ETF
NYSE ArcaVanEck Environmental Services ETF
$39.09
+0.61(+1.59%)
- O
- 38.69
- H
- 39.09
- L
- 38.69
- V
- 2.02K
⏱️ End-of-day dataAs of Oct 2, 2026
EVX — Latest News & Headlines
4 StoriesTwo-year data showed 12 of 16 melanoma patients responded. Evaxion will present new immune data in November. - Stock Titan
Two-year data showed 12 of 16 melanoma patients responded. Evaxion will present new immune data in November. Stock Titan
Evaxion sets November EVX-01 immune data presentation - Mugglehead Investment Magazine
Evaxion sets November EVX-01 immune data presentation Mugglehead Investment Magazine
A personalized cancer vaccine will feature in Evaxion (EVAX)'s oral and poster presentations at SITC 2026. - Stock Titan
A personalized cancer vaccine will feature in Evaxion (EVAX)'s oral and poster presentations at SITC 2026. Stock Titan
Evaxion to Unveil New Phase 2 Immune Data for Personalized Cancer Vaccine EVX-01 in October and November 2026 - TipRanks
Evaxion to Unveil New Phase 2 Immune Data for Personalized Cancer Vaccine EVX-01 in October and November 2026 TipRanks